PP
BIIB icon

PrairieView Partners’s Biogen BIIB Stock Holding History

PrairieView Partners’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-6
Closed -$1K – 386
2023
Q2 		$1K Hold
6
– – ﹤0.01% 409
2023
Q1 		$1K Hold
6
– – ﹤0.01% 389
2022
Q4 		$1K Hold
6
– – ﹤0.01% 429
2022
Q3 		$2K Hold
6
– – ﹤0.01% 384
2022
Q2 		$1K Hold
6
– – ﹤0.01% 425
2022
Q1 		$1K Buy
+6
New +$1.3K ﹤0.01% 418

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

PrairieView Partners's BIIB Position: Q3 2023 in Review

PrairieView Partners sold out of Biogen (BIIB) in Q3 2023, closing a stake of 6 shares — an estimated $1K sold.

PrairieView Partners first reported a position in BIIB in Q1 2022 and held it in 6 quarters. The position peaked at $2K in Q3 2022. 965 funds tracked by Wall St. Rank hold BIIB as of Q3 2023.

  • PrairieView Partners reported no remaining Biogen position as of Q3 2023 after selling out during the quarter.
  • PrairieView Partners sold 6 Biogen shares in Q3 2023, an estimated $1K.
  • PrairieView Partners first reported a position in Biogen in Q1 2022 and held it in 6 quarters.
  • PrairieView Partners's Biogen position peaked at $2K in Q3 2022.
  • 965 funds tracked by Wall St. Rank held Biogen as of Q3 2023.

Based on PrairieView Partners's 13F filing for Q3 2023, filed 23 Oct 2023.